Voyageur Pharmaceuticals (CVE:VM – Get Rating) had its price objective boosted by Fundamental Research from C$0.39 to C$0.55 in a report released on Tuesday morning, BayStreet.CA reports. They currently have a buy rating on the stock. Shares of VM stock opened at C$0.13 on Tuesday. Voyageur Pharmaceuticals has a twelve month low of C$0.08 and […]